New Cannabis Products: Lil Wayne's New Strain, Wayne Coyne's … – Yahoo Finance
As the cannabis market expands, it's not easy to keep track of the many products launching every week. But don’t worry, Benzinga always keeps you updated on the most interesting new cannabis products being launched.
Mr. Carter OG
GKUA, the cannabis brand founded by Lil Wayne, released a limited “sneak preview” of its new exclusive flower strain, Mr. Carter OG, in select California dispensaries. A larger, widespread release across California is scheduled for May.
The Mr. Carter OG strain was developed in partnership with 3C Farms, a heralded LA-based cultivator that has been in the game for two decades.
Love Yer Brain
Flaming Lips’ frontman, Wayne Coyne, launched his own cannabis brand, Love Yer Brain, which debuted in his home state of Oklahoma and released in partnership with Sands Lane Ventures and Ojos Del Mundo.
With a focus on inspiring creativity, the Flaming Lips aligns with Coyne’s persona and his love of art and music. The first product line for Love Yer Brain features brain-shaped gummies, available in three flavors (watermelon, green apple, raspberry) and two potencies (10mg and 25mg per gummy).
“Being authentic is key to having a successful cannabis brand, and I can’t think of a better person to be aligned with than Wayne Coyne, who has been instrumental in promoting creativity throughout his life in his music and art,” Sands Lane Ventures founder Evan Eneman told Benzinga.
Pamos
Pamos is a non-alcoholic cannabis spirit crafted from natural ingredients. It's also low in sugar and light on THC and CBD.
Available in a 750ml bottle (enough for roughly 16 servings), Pamos is crafted in California with locally sourced ingredients. The drink comes in two strengths: the "Micro Dose," which features 2mg of THC and 2mg of CBD per serving and costs $60 and the "Low Dose," which features 6mg of THC and 2mg of CBD per serving and costs $65.
Pamos is infused with citrus, sweet fruit and aromatic herbs and spices.
"Our vision at Pamos is to use our product line to break down barriers and remove any stigma that consumers may associate with cannabis consumption. We firmly believe that beverages that mimic the ritual and form of a traditional cocktail will help broaden the consumer set and provide the canna-curious consumer with an easy entry point into cannabis,” David Mukpo, Pamos’ CEO and co-founder, told Benzinga. “Our commitment is to meet the growth in the beverage segment with premium quality products that fit into mainstream consumption habits and address consumer focus on health and wellness. By combining cocktail form and cannabis function, Pamos provides people a way to enjoy the moment without any regrets."
Encuentra nuestro contenido en Español en El Planteo:
Mascotas y Marihuana: Hablamos con Cannvet, Agrupación Veterinaria Orientada al Cannabis Medicinal
¿Se Puede Tener una Sobredosis de Marihuana?
Puerto Rico Entra de Lleno a la Revolución Del Cáñamo con PR Hemp Biz
Courtesy images.
See more from Benzinga
Click here for options trades from Benzinga
The Week In Cannabis: PA, MD, Big Tobacco, GTI, Sundial, MedMen, Earnings, Financings And More
TechforCann, Europe's Cannabis Tech Accelerator, Raises Million
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Early retirement is a dream for many — that can turn into a nightmare.
We break down the latest earnings release from chip maker AMD.
Traders have placed a near definite chance for the Federal Reserve to slow down its pace of interest rate hikes once again on Wednesday, when it finishes its February meeting, and then perhaps a cut later this year. Investors are right to be on a slower pace of rate increases. After raising rates aggressively seven times last year, the Fed in its latest summary of economic projections said median interest rates will go as high as 5.1% in 2023.
GlaxoSmithKline has improved their forecasts for 2023 after results reveal strong sales of the pharmaceutical firm's shingles vaccine.
Another ugly quarter for the struggling Snapchat.
(Bloomberg) — Nassim Nicholas Taleb has a message for investors. Prepare for a painful return to reality.Most Read from BloombergSony Slashes PlayStation VR2 Headset Output After Pre-Orders DisappointBrexit Is Costing the UK £100 Billion a Year in Lost OutputPutin’s War in Ukraine Pushes Ex-Soviet States Toward New AlliesTrump Sues Journalist Bob Woodward for Releasing Interview RecordingsMicrosoft Studio Behind Halo Faces a Reboot on Years of Turmoil“Disneyland is over, the children go back to
Inflation made the headlines through most of last year, for all the worst reasons: it ran far too high, peaked above 9% in June, and the inflationary pressures pushed down hard on stock markets. The Fed jacked interest rates up their highest level in over a decade, risking recession to fight the rise in prices. Today, inflation is still in the headlines, although the tone has shifted. The annualized rate is trending downward; the December number came in at 6.5% year-over-year. While this is good
Berkshire Hathaway is the ultimate Warren Buffett stock. It is near an entry but is it a good buy? Here's what earnings and charts show for Berkshire stock.
Michael Burry, the hedge-fund manager at Scion Asset Management who correctly forecast the 2008 financial crisis, on Tuesday night sent out a one-word tweet: “Sell.” Burry didn’t elaborate, but it’s not hard to fill in the blanks. Assets like bitcoin and ARK Innovation ETF surged in January, in a seeming dash for trash on the view the Fed’s going to pivot to rate cuts soon, which is a lot to stomach for a value-focused investor like Burry.
Amazon.com Inc. is expected to reveal its first unprofitable year since 2014 this week — and expectations for the year aren't headed in a positive direction.
Yahoo Finance Live anchors discuss Amazon and Nike's rumored interest in buying out Peloton.
While stocks have rallied this past January, giving a good start to 2023, there’s no doubt that last year was decidedly bearish. A receding tide pulls back all boats, and that complicates the art of successful stock picking. The key to winning in a complicated environment like this is to find stocks that may be down – but are poised for a comeback. With this in mind, we've used the TipRank database to pinpoint two stocks that the analysts believe, in their words, are 'oversold' and are primed fo
What will it take for a new bull market to begin? The commonly accepted definition of a bull market is when stock prices rise 20% or more above their previous low. A new bull market realistically could be on the way in February.
In this article, we will take a look at the 10 most undervalued tech stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Tech Stocks to Buy According to Hedge Funds. Tech stocks took a beating last year as investors fled growth stocks amid rising inflation […]
Could he be right (again)?
Is Mr. Wonderful bailing on crypto? Not quite.
Boston Scientific Corp. stock (BSX) slid 5% in premarket trade Wednesday, after the medical device maker missed profit estimates for the fourth quarter. The company had net income of $126 million, or 9 cents a share, up from $80 million, or 6 cents a share, in the year-earlier period.
Bear markets can be a double-edged sword for investors. On the other hand, every bear market throughout history has eventually been cleared away by a bull market rally. Since most online brokerages have done away with commission fees and minimum deposit requirements, any amount of money — even $300 — can be the perfect amount to put to work during a bear market.
Joe Natiello is facing what you might call a "nice problem to have." Almost 20 years ago, the 64-year-old Westfield, New Jersey, resident took out a term life insurance policy, to help cover his family in case the worst happened. Next year, though, that policy is elapsing, and at his age, Natiello's insurance premiums would spike if he decided to extend coverage.
Markets rise after strong corporate results.
